mTOR Signaling Pathway – Cell Growth, Metabolism and Biomarker Analysis
What is the mTOR signaling pathway?
The mTOR signaling pathway (mechanistic Target of Rapamycin) is a master regulator of cell growth, metabolism, survival, and stress adaptation. It integrates signals from nutrients, growth factors, energy status, and cellular stress to maintain homeostasis and enable cells to adapt to changing environmental conditions.
mTOR functions as a central signaling hub controlling anabolic and catabolic processes, including protein synthesis, lipid metabolism, autophagy, and immune cell activation. Dysregulation of mTOR signaling is implicated in cancer, metabolic disorders, neurodegeneration, and immune dysfunction.
mTOR pathway activity can be efficiently assessed by measuring gene expression of core regulators, downstream targets, and pathway-specific biomarker signatures.
The structures, regulatory mechanism and functions of mTORC2.
Regulatory mechanism and function of the mammalian target of rapamycin complex 1 (mTORC1). (A) The structures and regulatory mechanism of mTORC1. (B) The downstream functions of mTORC1.
Key takeaways
Central regulator of cell growth, metabolism, and survival
Integrates nutrient, growth factor, and energy signals
Operates through two complexes: mTORC1 and mTORC2
Strongly linked to cancer, metabolic and immune diseases
Highly suitable for biomarker discovery and gene expression profiling
Regulation of mTOR complexes
mTOR exists in two functionally distinct complexes with complementary roles.
mTORC1 regulation
Activation: Responds to nutrients, insulin, growth factors, and PI3K/AKT signaling
Negative regulation: AMPK and the TSC complex inhibit mTORC1 under low energy, stress, or hypoxia
Functions: Promotes protein synthesis, lipid biosynthesis, cell growth, and suppresses autophagy
mTORC2 regulation
Activation: Primarily triggered by growth factors via PI3K
Functions: Regulates cytoskeletal organization, cell survival, and AKT activation
The mTOR pathway is activated by nutrients, growth factors, and cellular energy status. PI3K/AKT signaling, amino acids, and insulin stimulate mTORC1, while growth factors primarily regulate mTORC2.
mTORC1 promotes protein synthesis by phosphorylating key targets such as S6 kinase (S6K1) and 4E-BP1, increasing ribosome activity and translation efficiency.
mTORC1 mainly controls protein synthesis, metabolism, and autophagy in response to nutrients and energy levels, while mTORC2 regulates cell survival, cytoskeletal organization, and AKT activation in response to growth factors.
You can review the biomarker list for the mTOR pathway in the table below to see if it matches your research focus. If the targets you need are not included, you can customize your own SignArrays® by downloading and completing our Personalized SignArrays® information file. Send it to [email protected] to get started on your project.
Saxton RA et Sabatini DM. mTOR Signaling in Growth, Metabolism, and Disease. Cell. (2017)9;168(6):960-976.
Das A et al. mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging. Oxid Med Cell Longev. (2017).
Chamcheu JC et al. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy. Cells. (2019)31;8(8).
Wei X et al. Roles of mTOR Signaling in Tissue Regeneration. Cells. (2019)12;8(9).
Kwasnicki A et al. Involvement of mTOR signaling pathways in regulating growth and dissemination of metastatic brain tumors via EMT. Anticancer Res. (2015);35(2):689-96.
Paquette M e t al. mTOR Pathways in Cancer and Autophagy. Cancers (Basel). (2018);10(1).
Hua H e t al. Targeting mTOR for cancer therapy. J Hematol Oncol. (2019);12(1):71.
mTOR signaling pathway biomarker list
You can check the biomarker list included in this pathway, see below: